Skip to content

The research of effects and mechanisms of the recipe of Yi Qi San Ju prevention and treatment of metabolic syndrome with high blood pressure

The research of effects and mechanisms of the recipe of Yi Qi San Ju prevention and treatment of metabolic syndrome with high blood pressure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001633
Enrollment
Unknown
Registered
2011-06-22
Start date
2011-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic syndrome, hypertension

Interventions

A:Yi Qi San Ju decoction (TCM)

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: I. The criteria of metabolic syndrome (compound with the standard of IDF and the prevention and treatment of adult dyslipidemia china guide); 1. Central obesity (waist: male >90cm, female > 85cm); 2. With any one of the following three factors; (1) serum concentration of triglycerides: 1.7 mmol/L or more; (2) HDL concentration less than 1.0 mmol/L in menand less than 1.3 mmol/L in women; (3) plasma glucose concentration 5.6 mmol/L or more; 3. blood pressure: 130/85 mm Hg or more; II. age: 18-75.

Exclusion criteria

Exclusion criteria: 1. Acute hypertension (SBP>180mmHg, DBP>110mmHg), hypertension crisis, secondary hypertension(renal parenchymal hypertension, renovascular hypertension, primary aldosteronism, pheochromocytoma, hypercortisolism, aortic coarctation, hypertension of pregnancy), Secondary Obesity (thalamus fat, pituitary fat, Low thyroid function of obesity, Cushing syndrome); 2. Clinical organ damage of cardiovascular, brain, kidney, Retinal vascular and carotid artery which caused by hypertension; 3. Obesity damage such as bedsore, fracture; 4. Serious damage of function of liver and kidney disease (ALT>300U/L,AST>200U/L; BUN>20mmol/l, Cr>445mmol/l, Ccr<10ml/min); 5. The hypertension and obesity caused by drugs such as oral contraceptive, hormone therapy; 6. Malignant tumor; 7. The Survival time less than nine months caused by any reason; 8. The hypertension patient with the treatment of ARB/ACEI, diuretic, CCB, BB whose blood pressure less than 130/85 mmHg.

Design outcomes

Primary

MeasureTime frame
age, waistline, hipline, Waist to Hip Ratio, height, weight;24abpm;FBG, PBG, INS, PINS;TC, TG, HDL-c, LDL-c;MAU, MCA;adiponectin, leptin, TNF-a, IL-6, hs-CRP, PAI-1, t-PA;

Secondary

MeasureTime frame
BlutRoutineUntersuchung Untersuchung Blood routine;

Countries

China

Contacts

Public ContactWang Wenjian
wj6518@163.com+86 21 52888225

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 23, 2026